Introduction
Repeated blood culture sampling is common in critically ill neonates though precise indications are unknown.
Objectives
To describe clinical characteristics driving repeated blood culture sampling: clinical indications, time interval between cultures, and rates of blood culture-positivity.
Methods
Prospective multicenter study of characteristics for repeated blood culture sampling in neonates admitted to three tertiary-referral intensive care units (period 7/2013-12/2014) . Repeated blood culture samples were included when obtained within 14 days after the previous sample. Clinical sepsis is defined as the presence of 2 clinical signs and the duration of antibiotic therapy for ≥5 days. Blood cultures positive for skin commensals are considered contaminated if no 2 clinical signs and no CRP of > 2mg/dL are identified.
Results
Of the 413 initial blood culture samples in 286 neonates, 132 (32%) were repeated blood cultures sampled in 97 neonates, 42 of which had a birth-weight ≤1500 g. Repeated cultures resulted in: (1) no sepsis, i.e. no growth (n = 87, 65.9%) and contamination (n = 5, 3.8%), (2) clinical sepsis (n = 25, 18.9%), and (3) lab-confirmed sepsis (n = 15, 11.4%). Clinical characteristics of repeated cultures for the total and those three cohorts are in Figure 1 
Conclusions
CRP rise seems not a good indicator for repeated blood culturing, though mostly identified as an indicator in particular in the prior-ABT-cohort. Prior ABT influences indications and interval for repeated cultures but has no effect on blood culture-positivity. Repeated blood culture samples seems indicated when ≥2 clinical signs occur.
